Publikationen, an denen er mitarbeitet Pablo Mir Rivera (12)

2024

  1. Perspectives of Implementation of Closed-Loop Deep Brain Stimulation: From Neurological to Psychiatric Disorders

    Stereotactic and Functional Neurosurgery, Vol. 102, Núm. 1, pp. 40-54

2023

  1. Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease

    Movement Disorders, Vol. 38, Núm. 5, pp. 755-763

2021

  1. Levodopa-Induced Dyskinesia in Parkinson Disease Specifically Associates with Dopaminergic Depletion in Sensorimotor-Related Functional Subregions of the Striatum

    Clinical Nuclear Medicine, Vol. 46, Núm. 6, pp. E296-E306

2017

  1. A Bayesian spatial model for neuroimaging data based on biologically informed basis functions

    NeuroImage, Vol. 161, pp. 134-148

  2. Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease

    PLoS ONE, Vol. 12, Núm. 4

  3. Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype

    PLoS ONE, Vol. 12, Núm. 3

2015

  1. Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson’s disease using [123I]FP-CIT SPECT

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 1, pp. 112-119

2014

  1. Neuroimagen funcional en el diagnóstico de pacientes con síndrome parkinsoniano: Actualización y recomendaciones para el uso clínico

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 33, Núm. 4, pp. 215-226

2013

  1. Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 84, Núm. 2, pp. 122-129

  2. Elaboración de una plantilla de SPM para la normalización de imágenes de SPECT con 123I-Ioflupano

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 32, Núm. 6, pp. 350-356

2010

  1. Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson's disease

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 37, Núm. 3, pp. 556-564

2008

  1. Apolipoproteína ε4 en la demencia con cuerpos de Lewy

    Neurologia, Vol. 23, Núm. 3, pp. 152-156